Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis
Sun Kim,
Melike Hazal Can,
Tefera B Agizew,
Andrew F Auld,
Maria Elvira Balcells,
Stephanie Bjerrum,
Keertan Dheda,
Susan E Dorman,
Aliasgar Esmail,
Katherine Fielding,
Alberto L Garcia-Basteiro,
Colleen F Hanrahan,
Wakjira Kebede,
Mikashmi Kohli,
Anne F Luetkemeyer,
Carol Mita,
Byron W P Reeve,
Denise Rossato Silva,
Sedona Sweeney,
Grant Theron,
Anete Trajman,
Anna Vassall,
Joshua L Warren,
Marcel Yotebieng,
Ted Cohen and
Nicolas A Menzies
PLOS Medicine, 2025, vol. 22, issue 1, 1-18
Abstract:
Background: Globally, over one-third of pulmonary tuberculosis (TB) disease diagnoses are made based on clinical criteria after a negative bacteriological test result. There is limited information on the factors that determine clinicians’ decisions to initiate TB treatment when initial bacteriological test results are negative. Methods and findings: We performed a systematic review and individual patient data meta-analysis using studies conducted between January 2010 and December 2022 (PROSPERO: CRD42022287613). We included trials or cohort studies that enrolled individuals evaluated for TB in routine settings. In these studies, participants were evaluated based on clinical examination and routinely used diagnostics and were followed for ≥1 week after the initial test result. We used hierarchical Bayesian logistic regression to identify factors associated with treatment initiation following a negative result on an initial bacteriological test (e.g., sputum smear microscopy (SSM), Xpert MTB/RIF). Conclusions: Multiple factors influenced decisions to initiate TB treatment despite negative test results. Clinicians were substantially less likely to treat in the absence of a positive test result when using more sensitive, PCR-based diagnostics. Sun Kim and colleagues conducted a systematic review and individual patient data meta-analysis to investigate the factors that influence a clinician’s decision to initial TB treatment when bacteriological tests are negative.Why was this study done?: What did the researchers do and find?: What do these findings mean?:
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004502 (text/html)
https://journals.plos.org/plosmedicine/article/fil ... 04502&type=printable (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:plo:pmed00:1004502
DOI: 10.1371/journal.pmed.1004502
Access Statistics for this article
More articles in PLOS Medicine from Public Library of Science
Bibliographic data for series maintained by plosmedicine ().